Further, 64.2% (113/175) of patients bearing A-allele from CPS1 variant did not display hepatic fibrosis in liver biopsy vs. 53.4% (110/207) of patients without A-allele and without fibrosis (p = 0.03). This evidence concerns the gene CPS1 and fibrosis.